Industrial - Pollution & Treatment Controls
Compare Stocks
5 / 10Stock Comparison
CLIR vs CLNE vs AMTX vs PESI vs GEVO
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Refining & Marketing
Oil & Gas Refining & Marketing
Waste Management
Chemicals - Specialty
CLIR vs CLNE vs AMTX vs PESI vs GEVO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Pollution & Treatment Controls | Oil & Gas Refining & Marketing | Oil & Gas Refining & Marketing | Waste Management | Chemicals - Specialty |
| Market Cap | $254M | $507M | $213M | $207M | $493M |
| Revenue (TTM) | $2M | $439M | $209M | $59M | $174M |
| Net Income (TTM) | $-6M | $-99M | $-74M | $-18M | $-11M |
| Gross Margin | 32.8% | 11.7% | 3.4% | 4.1% | 23.4% |
| Operating Margin | -348.9% | 7.4% | -13.4% | -26.3% | -4.6% |
| Total Debt | $188K | $99M | $318M | $4M | $168M |
| Cash & Equiv. | $14M | $158M | $5M | $12M | $1M |
CLIR vs CLNE vs AMTX vs PESI vs GEVO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ClearSign Technolog… (CLIR) | 100 | 92.9 | -7.1% |
| Clean Energy Fuels … (CLNE) | 100 | 110.5 | +10.5% |
| Aemetis, Inc. (AMTX) | 100 | 390.0 | +290.0% |
| Perma-Fix Environme… (PESI) | 100 | 199.8 | +99.8% |
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLIR vs CLNE vs AMTX vs PESI vs GEVO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLIR is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.43, Low D/E 1.4%, current ratio 7.28x
CLNE is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- beta 1.19
- Beta 1.19, current ratio 2.32x
- Beta 1.19 vs PESI's 1.85
AMTX ranks third and is worth considering specifically for momentum.
- +140.0% vs CLIR's -10.6%
PESI is the clearest fit if your priority is long-term compounding.
- 178.6% 10Y total return vs AMTX's 31.1%
GEVO carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs AMTX's -22.3%
- -6.6% margin vs CLIR's -294.9%
- -1.7% ROA vs CLIR's -49.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs AMTX's -22.3% | |
| Quality / Margins | -6.6% margin vs CLIR's -294.9% | |
| Stability / Safety | Beta 1.19 vs PESI's 1.85 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +140.0% vs CLIR's -10.6% | |
| Efficiency (ROA) | -1.7% ROA vs CLIR's -49.8% |
CLIR vs CLNE vs AMTX vs PESI vs GEVO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CLIR vs CLNE vs AMTX vs PESI vs GEVO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CLNE leads in 2 of 6 categories
GEVO leads 1 • CLIR leads 0 • AMTX leads 0 • PESI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CLNE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLNE is the larger business by revenue, generating $439M annually — 203.9x CLIR's $2M. Profitability is closely matched — net margins range from -6.6% (GEVO) to -2.9% (CLIR). On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2M | $439M | $209M | $59M | $174M |
| EBITDAEarnings before interest/tax | -$7M | $62M | -$21M | -$14M | $18M |
| Net IncomeAfter-tax profit | -$6M | -$99M | -$74M | -$18M | -$11M |
| Free Cash FlowCash after capex | -$4M | $19M | -$38M | -$14M | -$35M |
| Gross MarginGross profit ÷ Revenue | +32.8% | +11.7% | +3.4% | +4.1% | +23.4% |
| Operating MarginEBIT ÷ Revenue | -3.5% | +7.4% | -13.4% | -26.3% | -4.6% |
| Net MarginNet income ÷ Revenue | -2.9% | -22.7% | -35.4% | -30.1% | -6.6% |
| FCF MarginFCF ÷ Revenue | -182.3% | +4.3% | -18.2% | -23.4% | -19.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -44.6% | +13.3% | +27.4% | -20.1% | +47.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -42.2% | +90.0% | +29.8% | -110.5% | +3.8% |
Valuation Metrics
CLNE leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, CLNE's 94.6x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $254M | $507M | $213M | $207M | $493M |
| Enterprise ValueMkt cap + debt − cash | $240M | $448M | $526M | $200M | $659M |
| Trailing P/EPrice ÷ TTM EPS | -43.91x | -2.29x | -2.44x | -14.89x | -14.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 94.64x | — | — | 102.12x |
| Price / SalesMarket cap ÷ Revenue | 70.54x | 1.19x | 1.02x | 3.36x | 3.07x |
| Price / BookPrice ÷ Book value/share | 17.17x | 0.90x | — | 4.11x | 1.01x |
| Price / FCFMarket cap ÷ FCF | — | 8.47x | — | — | — |
Profitability & Efficiency
GEVO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEVO delivers a -2.4% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-70 for CLIR. CLIR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEVO's 0.36x. On the Piotroski fundamental quality scale (0–9), CLNE scores 5/9 vs GEVO's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -69.9% | -17.2% | — | -34.5% | -2.4% |
| ROA (TTM)Return on assets | -49.8% | -9.2% | -29.3% | -20.2% | -1.7% |
| ROICReturn on invested capital | — | -9.4% | -70.3% | -21.7% | -2.8% |
| ROCEReturn on capital employed | -67.4% | -9.4% | -19.0% | -16.7% | -3.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 4 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.18x | — | 0.09x | 0.36x |
| Net DebtTotal debt minus cash | -$14M | -$59M | $313M | -$7M | $166M |
| Cash & Equiv.Liquid assets | $14M | $158M | $5M | $12M | $1M |
| Total DebtShort + long-term debt | $188,000 | $99M | $318M | $4M | $168M |
| Interest CoverageEBIT ÷ Interest expense | — | -1.07x | -0.27x | -42.14x | -0.04x |
Total Returns (Dividends Reinvested)
Evenly matched — AMTX and PESI and GEVO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PESI five years ago would be worth $14,563 today (with dividends reinvested), compared to $1,093 for CLIR. Over the past 12 months, AMTX leads with a +140.0% total return vs CLIR's -10.6%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs CLIR's -22.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.3% | +6.9% | +96.2% | -8.8% | -1.5% |
| 1-Year ReturnPast 12 months | -10.6% | +44.4% | +140.0% | +26.2% | +88.0% |
| 3-Year ReturnCumulative with dividends | -52.6% | -46.3% | +37.4% | +21.7% | +65.0% |
| 5-Year ReturnCumulative with dividends | -89.1% | -73.8% | -76.1% | +45.6% | -65.2% |
| 10-Year ReturnCumulative with dividends | -88.7% | -26.9% | +31.1% | +178.6% | -98.6% |
| CAGR (3Y)Annualised 3-year return | -22.1% | -18.7% | +11.2% | +6.8% | +18.2% |
Risk & Volatility
Evenly matched — CLNE and AMTX each lead in 1 of 2 comparable metrics.
Risk & Volatility
CLNE is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than PESI's 1.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMTX currently trades 82.1% from its 52-week high vs CLIR's 43.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 1.19x | 1.46x | 1.85x | 1.64x |
| 52-Week HighHighest price in past year | $11.20 | $3.11 | $3.80 | $16.50 | $2.97 |
| 52-Week LowLowest price in past year | $0.70 | $1.56 | $1.22 | $8.02 | $1.01 |
| % of 52W HighCurrent price vs 52-week peak | +43.1% | +74.3% | +82.1% | +67.7% | +68.4% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 44.6 | 58.2 | 41.5 | 53.5 |
| Avg Volume (50D)Average daily shares traded | 37K | 1.3M | 1.8M | 164K | 4.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: CLIR as "Buy", CLNE as "Buy", AMTX as "Buy", PESI as "Hold", GEVO as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -43.9% for AMTX (target: $2).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $3.50 | $1.75 | $18.00 | $3.50 |
| # AnalystsCovering analysts | 1 | 22 | 7 | 1 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.6% | 0.0% | 0.0% | 0.0% |
CLNE leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). GEVO leads in 1 (Profitability & Efficiency). 2 tied.
CLIR vs CLNE vs AMTX vs PESI vs GEVO: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is CLIR or CLNE or AMTX or PESI or GEVO a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 3% for Aemetis, Inc. (AMTX). Analysts rate ClearSign Technologies Corporation (CLIR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CLIR or CLNE or AMTX or PESI or GEVO?
Over the past 5 years, Perma-Fix Environmental Services, Inc.
(PESI) delivered a total return of +45. 6%, compared to -89. 1% for ClearSign Technologies Corporation (CLIR). Over 10 years, the gap is even starker: PESI returned +178. 6% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CLIR or CLNE or AMTX or PESI or GEVO?
By beta (market sensitivity over 5 years), Clean Energy Fuels Corp.
(CLNE) is the lower-risk stock at 1. 19β versus Perma-Fix Environmental Services, Inc. 's 1. 85β — meaning PESI is approximately 55% more volatile than CLNE relative to the S&P 500. On balance sheet safety, ClearSign Technologies Corporation (CLIR) carries a lower debt/equity ratio of 1% versus 36% for Gevo, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CLIR or CLNE or AMTX or PESI or GEVO?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 3% for Aemetis, Inc. (AMTX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CLIR or CLNE or AMTX or PESI or GEVO?
Gevo, Inc.
(GEVO) is the more profitable company, earning -21. 1% net margin versus -147. 4% for ClearSign Technologies Corporation — meaning it keeps -21. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEVO leads at -11. 7% versus -180. 4% for CLIR. At the gross margin level — before operating expenses — CLIR leads at 31. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CLIR or CLNE or AMTX or PESI or GEVO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is CLIR or CLNE or AMTX or PESI or GEVO better for a retirement portfolio?
For long-horizon retirement investors, Clean Energy Fuels Corp.
(CLNE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 19)). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLNE: -26. 9%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CLIR and CLNE and AMTX and PESI and GEVO?
These companies operate in different sectors (CLIR (Industrials) and CLNE (Energy) and AMTX (Energy) and PESI (Industrials) and GEVO (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CLIR is a small-cap high-growth stock; CLNE is a small-cap quality compounder stock; AMTX is a small-cap quality compounder stock; PESI is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.